Skip to main content
SpringerLink
Log in

Brain and whole body distribution ofN-isopropyl-4-iodoamphetamine (I-123) in humans: Comparison of radiopharmaceuticals marketed by different companies in Japan

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Iodine-123 (123I)-labeledN-isopropyl-4-iodoamphetamine (IMP) has been used as a cerebral blood flow (CBF) tracer for single-photon emission computed tomography (SPECT). An autoradiographic (ARG) method has been developed for the quantitation of CBF by IMP and SPECT. Two IMPs (IMPA and IMPB) produced by different radiopharmaceutical companies are marketed in Japan. In the present study, whole-body distributions including brain and blood of the two IMPs were compared in the same human subjects.

Methods

Two brain SPECT studies using IMPa or IMPb were performed on separate days in six young healthy men. Whole-body scans were also obtained with a large field-of-view single-head gamma camera. One-point arterial blood sampling was performed at 10 min after injection of IMP to measure both the radioactivity concentrations of whole blood and of octanol-extracted components.

Results

No significant differences between the two tracers were observed in body distribution, tracer kinetics in brain, or regional distribution in brain. However, the octanol extraction fraction in blood was significantly different between the two tracers. Radiochemical purity was slightly but significantly different between the tracers.

Conclusions

In the ARG method, arterial input function is determined by calibration of a standard input function with the radioactivity concentration of arterial whole blood. Because the standard input function in the ARG method was obtained using IMPa, the standard input function obtained for IMPb should be used when CBF is calculated by the ARG method with IMPB

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Winchell HS, Baldwin RM, Lin TH. Development of I-123- labeled amines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain.J Nucl Med 1980; 21: 940–946.

    PubMed  CAS  Google Scholar 

  2. Winchell HS, Horst WD, Braun L, Oldendorf WH, Hattner R, Parker H. AMsopropyl-[123I]p-iodoamphetamine: single- pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain.J Nucl Med 1980; 21: 947–952.

    PubMed  CAS  Google Scholar 

  3. Ito H, Iida H, Bloomfield PM, Murakami M, Inugami A, Kanno I, et al. Rapid calculation of regional cerebral blood flow and distribution volume using iodine- 123-iodoam- phetamine and dynamic SPECT.J Nucl Med 1995; 36:531- 536.

    PubMed  CAS  Google Scholar 

  4. Iida H, Itoh H, Nakazawa M, Hatazawa J, Nishimura H, Onishi Y, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT.J Nucl Med 1994; 35: 2019–2030.

    PubMed  CAS  Google Scholar 

  5. Ito H, Ishii K, Atsumi H, Inukai Y, Abe S, Sato M, et al. Error analysis of autoradiography method for measurement of cerebral blood flow by123I-IMP brain SPECT: a comparison study with table look-up method and microsphere model method.Ann Nucl Med 1995; 9: 185–190.

    Article  PubMed  CAS  Google Scholar 

  6. Iida H, Akutsu T, Endo K, Fukuda H, Inoue T, Ito H, et al. A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography.J Cereb Blood Flow Metab 1996; 16: 781–793.

    Article  PubMed  CAS  Google Scholar 

  7. Ogasawara K, Ito H, Sasoh M, Okuguchi T, Kobayashi M, Yukawa H, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using123I-N- isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.J Nucl Med 2003; 44: 520–525.

    PubMed  CAS  Google Scholar 

  8. Kimura K, Hashikawa K, Etani H, Uehara A, Kozuka T, Moriwaki H, et al. A new apparatus for brain imaging: four- head rotating gamma camera single-photon emission computed tomograph.J Nucl Med 1990; 31: 603–609.

    PubMed  CAS  Google Scholar 

  9. Chang LT. A method for attenuation correction in radionuclide computed tomography.IEEE Trans Nucl Sci 1978; 25: 638–643.

    Article  Google Scholar 

  10. Chang LT. Attenuation correction and incomplete projection in single photon emission computed tomography.IEEE Trans Nucl Sci 1979; 26: 2780–2789.

    Article  Google Scholar 

  11. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans.J Cereb Blood Flow Metab 1990; 10: 458–466.

    PubMed  CAS  Google Scholar 

  12. Rapin JR, Le Poncin-Lafltte M, Duterte D, Rips R, Morier E, Lassen NA. Iodoamphetamine as a new tracer for local cerebral blood flow in the rat: comparison with isopropyl- iodoamphetamine.J Cereb Blood Flow Metab 1984; 4: 270–274.

    PubMed  CAS  Google Scholar 

  13. Som P, Oster ZH, Yamamoto K, Meinken GE, Srivastava SC, Yonekura Y, et al. Some factors affecting the cerebral and extracerebral accumulation of N-isopropyl-p-iodo- amphetamine (IAMP).Int J Nucl Med Biol 1985; 12: 185- 196.

    Article  PubMed  CAS  Google Scholar 

  14. Kuhl DE, Barrio JR, Huang SC, Selin C, Ackermann RF, Lear JL, et al. Quantifying local cerebral blood flow byN- isopropyl-p-[123I]iodoamphetamine (IMP) tomography.J Nucl Med 1982; 23: 196–203.

    PubMed  CAS  Google Scholar 

  15. Nishizawa S, Tanada S, Yonekura Y, Fujita T, Mukai T, Saji H, et al. Regional dynamics of N-sopropyl-(123I)p- iodoamphetamine in human brain.J Nucl Med 1989; 30: 150–156.

    PubMed  CAS  Google Scholar 

  16. Iida H, Itoh H, Bloomfield PM, Munaka M, Higano S, Murakami M, et al. A method to quantitate cerebral blood flow using a rotating gamma camera and iodine-123 iodoamphetamine with one blood sampling.Eur J Nucl Med 1994; 21: 1072–1084.

    Article  PubMed  CAS  Google Scholar 

  17. Ito H, Kawashima R, Awata S, One S, Sato K, Goto R, et al. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique.J Nucl Med 1996; 37: 410–414.

    PubMed  CAS  Google Scholar 

  18. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease.Ann Neurol 1997; 42: 85–94.

    Article  PubMed  CAS  Google Scholar 

  19. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer’s disease by means of H2 15O positron emission tomography.Eur J Nucl Med 1997; 24: 670–673.

    PubMed  CAS  Google Scholar 

  20. Baldwin RM, Wu JL.In vivo chemistry of iofetamine HCl iodine-123 (IMP).J Nucl Med 1988; 29: 122–124.

    PubMed  CAS  Google Scholar 

  21. Dadachova E, Bouzahzah B, Zuckier LS, Pestell RG. Rhenium- 188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS).Nucl Med Biol 2002; 29: 13–18.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Radiology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University, Japan

    Hiroshi Ito, Tachio Sato, Kentaro Inoue, Miho Shidahara & Hiroshi Fukuda

  2. Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, 4-9-1 Anagawa, 263-8555, Inage-ku, Chiba, Japan

    Hiroshi Ito & Tetsuya Suhara

  3. Tohoku University Hospital, Japan

    Hayato Odagiri

  4. Division of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Japan

    Jun Hatazawa

Authors
  1. Hiroshi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tachio Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hayato Odagiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kentaro Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miho Shidahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tetsuya Suhara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jun Hatazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroshi Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Ito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, H., Sato, T., Odagiri, H. et al. Brain and whole body distribution ofN-isopropyl-4-iodoamphetamine (I-123) in humans: Comparison of radiopharmaceuticals marketed by different companies in Japan. Ann Nucl Med 20, 493–498 (2006). https://doi.org/10.1007/BF02987259

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02987259

Key words

Search

Navigation